ID   BCAT1_HUMAN             Reviewed;         386 AA.
AC   P54687; B3KY27; B7Z2M5; B7Z5L0; F5H5E4; Q68DQ7; Q96MY9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Branched-chain-amino-acid aminotransferase, cytosolic;
DE            Short=BCAT(c);
DE            EC=2.6.1.42;
DE   AltName: Full=Protein ECA39;
GN   Name=BCAT1; Synonyms=BCT1, ECA39;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-330.
RC   TISSUE=Fetal brain;
RX   PubMed=8692959; DOI=10.1073/pnas.93.14.7143;
RA   Schuldiner O., Eden A., Ben-Yosef T., Yanuka O., Simchen G.,
RA   Benvenisty N.;
RT   "ECA39, a conserved gene regulated by c-Myc in mice, is involved in
RT   G1/S cell cycle regulation in yeast.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:7143-7148(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 5).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH GABAPENTIN.
RX   PubMed=16141215; DOI=10.1074/jbc.M506486200;
RA   Goto M., Miyahara I., Hirotsu K., Conway M., Yennawar N., Islam M.M.,
RA   Hutson S.M.;
RT   "Structural determinants for branched-chain aminotransferase isozyme-
RT   specific inhibition by the anticonvulsant drug gabapentin.";
RL   J. Biol. Chem. 280:37246-37256(2005).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-386 IN COMPLEX WITH
RP   INHIBITOR.
RX   PubMed=16143519; DOI=10.1016/j.bmcl.2005.07.058;
RA   Hu L.Y., Boxer P.A., Kesten S.R., Lei H.J., Wustrow D.J.,
RA   Moreland D.W., Zhang L., Ahn K., Ryder T.R., Liu X., Rubin J.R.,
RA   Fahnoe K., Carroll R.T., Dutta S., Fahnoe D.C., Probert A.W.,
RA   Roof R.L., Rafferty M.F., Kostlan C.R., Scholten J.D., Hood M.,
RA   Ren X.D., Schielke G.P., Su T.Z., Taylor C.P., Mistry A.,
RA   McConnell P., Hasemann C., Ohren J.;
RT   "The design and synthesis of human branched-chain amino acid
RT   aminotransferase inhibitors for treatment of neurodegenerative
RT   diseases.";
RL   Bioorg. Med. Chem. Lett. 16:2337-2340(2006).
CC   -!- FUNCTION: Catalyzes the first reaction in the catabolism of the
CC       essential branched chain amino acids leucine, isoleucine, and
CC       valine.
CC   -!- CATALYTIC ACTIVITY: L-leucine + 2-oxoglutarate = 4-methyl-2-
CC       oxopentanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-isoleucine + 2-oxoglutarate = (S)-3-methyl-
CC       2-oxopentanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-valine + 2-oxoglutarate = 3-methyl-2-
CC       oxobutanoate + L-glutamate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P54687-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P54687-2; Sequence=VSP_042651, VSP_042652;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P54687-3; Sequence=VSP_042652;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P54687-4; Sequence=VSP_043560;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P54687-5; Sequence=VSP_046057;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: During embryogenesis, expressed in the brain
CC       and kidney. Overexpressed in MYC-induced tumors such as Burkitt's
CC       lymphoma.
CC   -!- SIMILARITY: Belongs to the class-IV pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U21551; AAB08528.1; -; mRNA.
DR   EMBL; AK056255; BAB71129.1; -; mRNA.
DR   EMBL; AK128527; BAG54689.1; -; mRNA.
DR   EMBL; AK294879; BAH11911.1; -; mRNA.
DR   EMBL; AK299088; BAH12946.1; -; mRNA.
DR   EMBL; CR749308; CAH18163.1; -; mRNA.
DR   EMBL; AC023796; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026310; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092867; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS44845.1; -. [P54687-1]
DR   CCDS; CCDS53760.1; -. [P54687-4]
DR   CCDS; CCDS53761.1; -. [P54687-5]
DR   CCDS; CCDS53762.1; -. [P54687-2]
DR   CCDS; CCDS53763.1; -. [P54687-3]
DR   RefSeq; NP_001171562.1; NM_001178091.1. [P54687-3]
DR   RefSeq; NP_001171563.1; NM_001178092.1. [P54687-2]
DR   RefSeq; NP_001171564.1; NM_001178093.1. [P54687-5]
DR   RefSeq; NP_001171565.1; NM_001178094.1. [P54687-4]
DR   RefSeq; NP_005495.2; NM_005504.6. [P54687-1]
DR   UniGene; Hs.438993; -.
DR   PDB; 2ABJ; X-ray; 2.20 A; A/D/G/J=21-386.
DR   PDB; 2COG; X-ray; 2.10 A; A/B=1-386.
DR   PDB; 2COI; X-ray; 1.90 A; A/B=1-386.
DR   PDB; 2COJ; X-ray; 2.40 A; A/B=1-386.
DR   PDBsum; 2ABJ; -.
DR   PDBsum; 2COG; -.
DR   PDBsum; 2COI; -.
DR   PDBsum; 2COJ; -.
DR   ProteinModelPortal; P54687; -.
DR   SMR; P54687; -.
DR   BioGrid; 107061; 37.
DR   IntAct; P54687; 3.
DR   MINT; MINT-1180265; -.
DR   STRING; 9606.ENSP00000443459; -.
DR   BindingDB; P54687; -.
DR   ChEMBL; CHEMBL4679; -.
DR   DrugBank; DB00996; Gabapentin.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00167; L-Isoleucine.
DR   DrugBank; DB00149; L-Leucine.
DR   DrugBank; DB00161; L-Valine.
DR   DrugBank; DB07544; N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; P54687; -.
DR   PhosphoSitePlus; P54687; -.
DR   BioMuta; BCAT1; -.
DR   DMDM; 215274162; -.
DR   EPD; P54687; -.
DR   MaxQB; P54687; -.
DR   PaxDb; P54687; -.
DR   PeptideAtlas; P54687; -.
DR   PRIDE; P54687; -.
DR   Ensembl; ENST00000261192; ENSP00000261192; ENSG00000060982. [P54687-1]
DR   Ensembl; ENST00000342945; ENSP00000339805; ENSG00000060982. [P54687-2]
DR   Ensembl; ENST00000538118; ENSP00000440817; ENSG00000060982. [P54687-4]
DR   Ensembl; ENST00000539282; ENSP00000443459; ENSG00000060982. [P54687-5]
DR   Ensembl; ENST00000539780; ENSP00000440827; ENSG00000060982. [P54687-3]
DR   GeneID; 586; -.
DR   KEGG; hsa:586; -.
DR   UCSC; uc001rgc.4; human. [P54687-1]
DR   CTD; 586; -.
DR   DisGeNET; 586; -.
DR   GeneCards; BCAT1; -.
DR   HGNC; HGNC:976; BCAT1.
DR   HPA; HPA048592; -.
DR   MIM; 113520; gene.
DR   neXtProt; NX_P54687; -.
DR   OpenTargets; ENSG00000060982; -.
DR   PharmGKB; PA25288; -.
DR   eggNOG; KOG0975; Eukaryota.
DR   eggNOG; COG0115; LUCA.
DR   GeneTree; ENSGT00390000009532; -.
DR   HOGENOM; HOG000276704; -.
DR   HOVERGEN; HBG050678; -.
DR   InParanoid; P54687; -.
DR   KO; K00826; -.
DR   OMA; FIAHWKD; -.
DR   OrthoDB; EOG091G07KO; -.
DR   PhylomeDB; P54687; -.
DR   TreeFam; TF300882; -.
DR   BRENDA; 2.6.1.42; 2681.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; P54687; -.
DR   ChiTaRS; BCAT1; human.
DR   EvolutionaryTrace; P54687; -.
DR   GenomeRNAi; 586; -.
DR   PRO; PR:P54687; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000060982; -.
DR   CleanEx; HS_BCAT1; -.
DR   ExpressionAtlas; P54687; baseline and differential.
DR   Genevisible; P54687; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0004084; F:branched-chain-amino-acid transaminase activity; EXP:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0052656; F:L-isoleucine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052654; F:L-leucine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052655; F:L-valine transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009082; P:branched-chain amino acid biosynthetic process; TAS:ProtInc.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0009098; P:leucine biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009099; P:valine biosynthetic process; IBA:GO_Central.
DR   CDD; cd01557; BCAT_beta_family; 1.
DR   InterPro; IPR001544; Aminotrans_IV.
DR   InterPro; IPR018300; Aminotrans_IV_CS.
DR   InterPro; IPR005786; B_amino_transII.
DR   InterPro; IPR033939; BCAT_family.
DR   Pfam; PF01063; Aminotran_4; 1.
DR   PIRSF; PIRSF006468; BCAT1; 1.
DR   SUPFAM; SSF56752; SSF56752; 1.
DR   TIGRFAMs; TIGR01123; ilvE_II; 1.
DR   PROSITE; PS00770; AA_TRANSFER_CLASS_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Amino-acid biosynthesis; Aminotransferase;
KW   Branched-chain amino acid biosynthesis; Complete proteome; Cytoplasm;
KW   Polymorphism; Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN         1    386       Branched-chain-amino-acid
FT                                aminotransferase, cytosolic.
FT                                /FTId=PRO_0000103292.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     222    222       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     25       MKDCSNGCSAECTGEGGSKEVVGTF -> M (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042651.
FT   VAR_SEQ       1      2       MK -> M (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043560.
FT   VAR_SEQ       1      2       MK -> MASPLRSAAALARQ (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046057.
FT   VAR_SEQ      94    130       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042652.
FT   VARIANT      59     59       T -> M (in dbSNP:rs17374285).
FT                                /FTId=VAR_047681.
FT   VARIANT     321    321       E -> K (in dbSNP:rs7313020).
FT                                /FTId=VAR_019614.
FT   VARIANT     330    330       G -> S (in dbSNP:rs1057204).
FT                                {ECO:0000269|PubMed:8692959}.
FT                                /FTId=VAR_047682.
FT   CONFLICT      2      2       Missing (in Ref. 1; AAB08528).
FT                                {ECO:0000305}.
FT   CONFLICT      8      8       Missing (in Ref. 1; AAB08528).
FT                                {ECO:0000305}.
FT   CONFLICT    165    165       T -> A (in Ref. 1; AAB08528).
FT                                {ECO:0000305}.
FT   CONFLICT    237    237       A -> D (in Ref. 1; AAB08528).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       E -> R (in Ref. 1; AAB08528).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       Q -> P (in Ref. 2; BAH11911).
FT                                {ECO:0000305}.
FT   CONFLICT    317    317       T -> S (in Ref. 2; BAB71129).
FT                                {ECO:0000305}.
FT   HELIX        27     29       {ECO:0000244|PDB:2COI}.
FT   HELIX        44     46       {ECO:0000244|PDB:2ABJ}.
FT   TURN         49     51       {ECO:0000244|PDB:2COG}.
FT   STRAND       55     63       {ECO:0000244|PDB:2COI}.
FT   TURN         64     66       {ECO:0000244|PDB:2COI}.
FT   STRAND       72     75       {ECO:0000244|PDB:2COI}.
FT   STRAND       79     81       {ECO:0000244|PDB:2COI}.
FT   HELIX        86     89       {ECO:0000244|PDB:2COI}.
FT   STRAND       93     95       {ECO:0000244|PDB:2COI}.
FT   STRAND       98    102       {ECO:0000244|PDB:2COI}.
FT   STRAND      108    112       {ECO:0000244|PDB:2COI}.
FT   HELIX       113    126       {ECO:0000244|PDB:2COI}.
FT   HELIX       134    147       {ECO:0000244|PDB:2COI}.
FT   HELIX       149    151       {ECO:0000244|PDB:2COI}.
FT   STRAND      154    157       {ECO:0000244|PDB:2COI}.
FT   STRAND      159    168       {ECO:0000244|PDB:2COI}.
FT   STRAND      179    190       {ECO:0000244|PDB:2COI}.
FT   STRAND      202    206       {ECO:0000244|PDB:2COI}.
FT   HELIX       225    228       {ECO:0000244|PDB:2COI}.
FT   HELIX       231    238       {ECO:0000244|PDB:2COI}.
FT   TURN        239    241       {ECO:0000244|PDB:2COI}.
FT   STRAND      243    249       {ECO:0000244|PDB:2COI}.
FT   TURN        250    253       {ECO:0000244|PDB:2COI}.
FT   STRAND      254    258       {ECO:0000244|PDB:2COI}.
FT   STRAND      261    268       {ECO:0000244|PDB:2COI}.
FT   STRAND      274    278       {ECO:0000244|PDB:2COI}.
FT   STRAND      282    285       {ECO:0000244|PDB:2COI}.
FT   HELIX       289    301       {ECO:0000244|PDB:2COI}.
FT   STRAND      303    308       {ECO:0000244|PDB:2COI}.
FT   HELIX       313    320       {ECO:0000244|PDB:2COI}.
FT   TURN        321    323       {ECO:0000244|PDB:2COI}.
FT   STRAND      325    332       {ECO:0000244|PDB:2COI}.
FT   TURN        333    335       {ECO:0000244|PDB:2COI}.
FT   STRAND      336    351       {ECO:0000244|PDB:2COI}.
FT   HELIX       353    357       {ECO:0000244|PDB:2COI}.
FT   HELIX       360    373       {ECO:0000244|PDB:2COI}.
FT   STRAND      382    384       {ECO:0000244|PDB:2COI}.
SQ   SEQUENCE   386 AA;  42966 MW;  A43535303A702512 CRC64;
     MKDCSNGCSA ECTGEGGSKE VVGTFKAKDL IVTPATILKE KPDPNNLVFG TVFTDHMLTV
     EWSSEFGWEK PHIKPLQNLS LHPGSSALHY AVELFEGLKA FRGVDNKIRL FQPNLNMDRM
     YRSAVRATLP VFDKEELLEC IQQLVKLDQE WVPYSTSASL YIRPTFIGTE PSLGVKKPTK
     ALLFVLLSPV GPYFSSGTFN PVSLWANPKY VRAWKGGTGD CKMGGNYGSS LFAQCEAVDN
     GCQQVLWLYG EDHQITEVGT MNLFLYWINE DGEEELATPP LDGIILPGVT RRCILDLAHQ
     WGEFKVSERY LTMDDLTTAL EGNRVREMFG SGTACVVCPV SDILYKGETI HIPTMENGPK
     LASRILSKLT DIQYGREESD WTIVLS
//
